Methods of induction of labor in intrauterine fetal demise: a comparative study
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20174033Keywords:
IUFD, Mifepristone, Misoprostol, OxytocinAbstract
Background: This study was undertaken to evaluate and compare the efficacies of two different regimen for induction of labour in IUFD in an effort to find a better management of woman with IUFD.
Methods: It was a hospital based prospective comparative study taken up in the Department of Obstetrics and Gynaecology, Assam Medical College and Hospital (AMCH), Dibrugarh for a period of 1 year. A total number of 90 cases were selected and randomly divided into 2 groups. The two groups were induced using regimen recommended by the RCOG. Group A was induced with Mifepristone - Misoprostol Combined Regimen while Group B was induced with only Misoprostol.
Results: Both the groups were found to be comparable with respect to mean Pre – induction Bishops score. The mean Induction to Onset of Labour Interval and Induction to Delivery Interval were significantly less in Group A as compared to Group B. Mean dose of Misoprostol required was less in Group A compared to Group B. In terms of side effects tolerance to Group A was better than Group B.
Conclusions: It was observed in the study that both the regimen were equally safe, easy to administer and affordable but the Combination Regimen had a slight edge over misoprostol alone regimen in terms of tolerance, fewer side effects and efficacy with regard to early onset of labour, shorter Induction to Delivery Interval and relatively less dose of misoprostol than misoprostol alone regimen.
References
Blencowe H, Cousens S, Jassir FB, Say L, Chou D, Mathers C et al. National, regional, and worldwide estimates of stillbirth rates in 2015, with trends from 2000: a systematic analysis. Lancet Global Health. 2016;4(2):98-108.
Fretts RC. Fetal death and stillbirth: Incidence, etiology, and prevention. UpToDate. 2016.
World Health Organization. International statistical classification of diseases and related health problems. World Health Organization; 2004.
WHO. Maternal, newborn, child and adolescent health. http://www.who.int/maternal_child_adolescent/epidemiology/stillbirth/en/ (Accessed on June 15, 2016)
Silver TM. Fetal death. Obstet Gynecol. 2007;109:153-67.
Royal College of Obstetricians and Gynaecologists (RCOG). Late intrauterine fetal death and stillbirth. (Green-top guideline; no. 55). London (UK). RCOG. 2010:33.
Cabrol D, d'Yvoire MB, Mermet E, Cedard L, Sureau C, Baulieu EE. Induction of labour with mifepristone after intrauterine fetal death. Lancet. 1985;326(8462):1019.
National Institute for Health and Clinical Excellence. Clinical guideline no. 70: Induction of labour. London: National Institute for Health and Clinical Excellence. 2008. Available at http:// www.nice.org.uk/ nicemedia/pdf/ CG070NICE Guideline.pdf
WHO recommendations for induction of labour. World Health Organization. 2011. Available at http://apps.who.int/iris/bitstream/10665/44531/1/9789241501156_eng.pdf
Väyrynen W, Heikinheimo O, Nuutila M. Misoprostol-only versus mifepristone plus misoprostol in induction of labor following intrauterine fetal death. Acta Obstetricia et Gynecologica Scandinavica. 2007;86(6):701-5.
Sharma D, Singhal SR, Poonam, Paul A, Kunika. Comparison of mifepristone combination with misoprostol and misoprostol alone in the management of intrauterine death: condensation - misoprostol and mifepristone combination is more effective than misoprostol alone in the management of intrauterine death. Taiwan J Obstet Gynecol. 2011;50(3):322-5.
Panda S, Jha V, Singh S. Department of Obstetrics and Gynecology, Neigrihms, India. JFRH. 2013;7(4):177-9.
Praveena G, Shameem VP, Rao A, Rao B. Mifepristone plus misoprostol versus only-misoprostol in induction of labour in intra uterine fetal death. Int J Pharm Biomed Res 2013;4:108-10.
Agrawal A, Basnet P, Thakur A, Rizal P, Rai R. Induction of labor using misoprostol with or without mifepristone in intrauterine death. J Nepal Med Assoc. 2014;52(194):785-90.
